trial
as of 2026-07-01Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole)
NCTId NCT07266792
at a glance
Phase 1 · Completed
Enrollment 36 (actual)
Sponsored by Humanis Saglık Anonim Sirketi
Primary completion 2025-08-04
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
36 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2025-06-22
Primary completion
2025-08-04
Eligibility
ALL · 45 Years · 65 Years
Interventions & indications
Sponsors
Humanis Saglık Anonim SirketiLead Sponsor
Sites
1 total
Ahmedabad, India
Facts & assertions
4 sourced
Enrollment
36
Phase
PHASE1
Primary Completion Date
2025-08-04
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
indication
indication